Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 53

1.

A novel mixed living high training low intervention and the hematological module of the athlete biological passport.

Voss SC, Al-Hamad K, Samsam W, Cherif A, Georgakopoulos C, Al Maadheed M, Balanos G, Lucas S, Sottas PE, Wilson M, Townsend N.

Drug Test Anal. 2019 Dec 30. doi: 10.1002/dta.2723. [Epub ahead of print]

PMID:
31889433
2.

The Olympia Declaration.

Pitsiladis YP, Abatzis-Papadopoulos M, Ali N, Aggeloudis S, Atkinson C, Constandache B, Ganus Y, Geladas N, Giakoumakis SI, Güner R, Howman D, Lima GHO, Khristenko E, Koskolou M, Klissouras V, Ladikas M, Loland S, McNamee MJ, Pardos BM, Natsis K, Nicholson P, Betancurt JO, Angeloudis K, Pappas E, Peteraitis M, Petróczi A, Papadopoulou T, Pigozzi F, Saugy M, Simon P, Singleton P, Sizikova E, Sottas PE, Tanaka M, Wang G, Yang H.

Curr Sports Med Rep. 2019 Dec;18(12):448-451. doi: 10.1249/JSR.0000000000000660. No abstract available.

PMID:
31834176
3.

Combined administration of microdoses of growth hormone and erythropoietin: Effects on performance and evaluation of GH detection capability using anti-doping methods.

Marchand A, Martin JA, Collot D, Hoang O, Roulland I, Semence F, Sottas PE, Audran M, Varlet-Marie E.

Drug Test Anal. 2019 Nov;11(11-12):1698-1713. doi: 10.1002/dta.2674. Epub 2019 Aug 16.

PMID:
31301268
4.

Standardization of reticulocyte counts in the athlete biological passport.

Naud JF, Giraud S, Robinson N, Desharnais P, Ericsson M, Saugy M, Kuuranne T, Ayotte C, Boghosian T, Aikin R, Sottas PE.

Int J Lab Hematol. 2019 Jun;41(3):387-391. doi: 10.1111/ijlh.12988. Epub 2019 Feb 19.

PMID:
30779426
5.

LC-HRMS Metabolomics for Untargeted Diagnostic Screening in Clinical Laboratories: A Feasibility Study.

Rochat B, Mohamed R, Sottas PE.

Metabolites. 2018 Jun 15;8(2). pii: E39. doi: 10.3390/metabo8020039.

6.

Athlete Performance Monitoring in Anti-Doping.

Hopker J, Schumacher YO, Fedoruk M, Mørkeberg J, Bermon S, Iljukov S, Aikin R, Sottas PE.

Front Physiol. 2018 Mar 23;9:232. doi: 10.3389/fphys.2018.00232. eCollection 2018. No abstract available.

7.

Validation of whole-blood transcriptome signature during microdose recombinant human erythropoietin (rHuEpo) administration.

Wang G, Durussel J, Shurlock J, Mooses M, Fuku N, Bruinvels G, Pedlar C, Burden R, Murray A, Yee B, Keenan A, McClure JD, Sottas PE, Pitsiladis YP.

BMC Genomics. 2017 Nov 14;18(Suppl 8):817. doi: 10.1186/s12864-017-4191-7.

8.

The Athlete Biological Passport: How to Personalize Anti-Doping Testing across an Athlete's Career?

Robinson N, Sottas PE, Schumacher YO.

Med Sport Sci. 2017;62:107-118. doi: 10.1159/000460722. Epub 2017 Jun 2.

PMID:
28578329
9.

A step towards removing plasma volume variance from the Athlete's Biological Passport: The use of biomarkers to describe vascular volumes from a simple blood test.

Lobigs LM, Sottas PE, Bourdon PC, Nikolovski Z, El-Gingo M, Varamenti E, Peeling P, Dawson B, Schumacher YO.

Drug Test Anal. 2018 Feb;10(2):294-300. doi: 10.1002/dta.2219. Epub 2017 Jul 27.

PMID:
28548390
10.

The use of biomarkers to describe plasma-, red cell-, and blood volume from a simple blood test.

Lobigs LM, Sottas PE, Bourdon PC, Nikolovski Z, El-Gingo M, Varamenti E, Peeling P, Dawson B, Schumacher YO.

Am J Hematol. 2017 Jan;92(1):62-67. doi: 10.1002/ajh.24577.

11.

Validation of a Blood Stability Score as an easy-to-use blood sample quality index.

Robinson N, Kirchbichler A, Banuls O, Mader M, Aikin R, Sottas PE, D'Onofrio G.

Int J Lab Hematol. 2016 Dec;38(6):685-693. doi: 10.1111/ijlh.12557. Epub 2016 Aug 30.

PMID:
27572141
12.

Metabotype analysis for personalized biology: a new bioanalytical territory for high-resolution MS.

Rochat B, Favre A, Sottas PE.

Bioanalysis. 2013 May;5(10):1149-52. doi: 10.4155/bio.13.79. No abstract available. Erratum in: Bioanalysis. 2013 Jul;5(13):1706. Bertrand, Rochat [corrected to Rochat, Bertrand]; Amelie, Favre [corrected to Favre, Amelie]; Pierre-Edouard, Sottas [corrected to Sottas, Pierre-Edouard].

PMID:
23721437
13.

Statistical discrimination of steroid profiles in doping control with support vector machines.

Van Renterghem P, Sottas PE, Saugy M, Van Eenoo P.

Anal Chim Acta. 2013 Mar 20;768:41-8. doi: 10.1016/j.aca.2013.01.003. Epub 2013 Jan 14.

PMID:
23473248
14.

Adaptive Bayesian approach to clinical trial renal impairment biomarker signal from urea and creatinine.

Sottas PE, Kapke GF, Leroux JM.

Int J Biol Sci. 2013;9(2):156-63. doi: 10.7150/ijbs.5225. Epub 2013 Jan 26.

15.

Adaptive Bayesian analysis of serum creatinine as a marker for drug-induced renal impairment in an early-phase clinical trial.

Sottas PE, Kapke GF, Leroux JM.

Clin Chem. 2012 Nov;58(11):1592-6. doi: 10.1373/clinchem.2012.193698. Epub 2012 Sep 18.

PMID:
22991423
16.

Evolving concepts and techniques for anti-doping.

Friedmann T, Flenker U, Georgakopoulos C, Alsayrafi M, Sottas PE, Williams SA, Gill RD.

Bioanalysis. 2012 Jul;4(13):1667-80. doi: 10.4155/bio.12.146.

PMID:
22831482
17.

Current implementation and future of the Athlete Biological Passport.

Sottas PE, Vernec A.

Bioanalysis. 2012 Jul;4(13):1645-52. doi: 10.4155/bio.12.130.

PMID:
22831480
18.

Patient-specific measures of a biomarker for the generation of individual reference intervals: hemoglobin as example.

Sottas PE, Kapke GF, Vesterqvist O, Leroux JM.

Transl Res. 2011 Dec;158(6):360-8. doi: 10.1016/j.trsl.2011.08.005. Epub 2011 Sep 3.

PMID:
22061043
19.

Hemoglobin mass and biological passport for the detection of autologous blood doping.

Pottgiesser T, Echteler T, Sottas PE, Umhau M, Schumacher YO.

Med Sci Sports Exerc. 2012 May;44(5):835-43. doi: 10.1249/MSS.0b013e31823bcfb6.

PMID:
21988933
20.

Fluorescence flow cytometer to determine urine particle reference intervals in doping control samples.

Robinson N, Sottas PE, Saugy M.

Forensic Sci Int. 2011 Dec 10;213(1-3):95-100. doi: 10.1016/j.forsciint.2011.07.054. Epub 2011 Sep 1.

PMID:
21889276
21.

The athlete biological passport.

Sottas PE, Robinson N, Rabin O, Saugy M.

Clin Chem. 2011 Jul;57(7):969-76. doi: 10.1373/clinchem.2011.162271. Epub 2011 May 19. Review.

PMID:
21596947
22.

A pilot study on subject-based comprehensive steroid profiling: novel biomarkers to detect testosterone misuse in sports.

Van Renterghem P, Van Eenoo P, Sottas PE, Saugy M, Delbeke F.

Clin Endocrinol (Oxf). 2011 Jul;75(1):134-40. doi: 10.1111/j.1365-2265.2011.03992.x.

PMID:
21521264
23.

Prevalence of blood doping in samples collected from elite track and field athletes.

Sottas PE, Robinson N, Fischetto G, Dollé G, Alonso JM, Saugy M.

Clin Chem. 2011 May;57(5):762-9. doi: 10.1373/clinchem.2010.156067. Epub 2011 Mar 22.

PMID:
21427381
24.

Detection of autologous blood doping with adaptively evaluated biomarkers of doping: a longitudinal blinded study.

Pottgiesser T, Sottas PE, Echteler T, Robinson N, Umhau M, Schumacher YO.

Transfusion. 2011 Aug;51(8):1707-15. doi: 10.1111/j.1537-2995.2011.03076.x. Epub 2011 Mar 7.

PMID:
21382045
25.

Subject-based steroid profiling and the determination of novel biomarkers for DHT and DHEA misuse in sports.

Van Renterghem P, Van Eenoo P, Sottas PE, Saugy M, Delbeke F.

Drug Test Anal. 2010 Nov-Dec;2(11-12):582-8. doi: 10.1002/dta.206. Epub 2010 Dec 1.

PMID:
21204290
26.

Stability and robustness of blood variables in an antidoping context.

Robinson N, Sottas PE, Pottgiesser T, Schumacher YO, Saugy M.

Int J Lab Hematol. 2011 Apr;33(2):146-53. doi: 10.1111/j.1751-553X.2010.01256.x. Epub 2010 Aug 16.

PMID:
20718874
27.
28.

IEF pattern classification-derived criteria for the identification of epoetin-delta in urine.

Lamon S, Boccard J, Sottas PE, Glatz N, Wuerzner G, Robinson N, Saugy M.

Electrophoresis. 2010 Jun;31(12):1918-24. doi: 10.1002/elps.200900645.

PMID:
20564689
29.

Are 10 min of seating enough to guarantee stable haemoglobin and haematocrit readings for the athlete's biological passport?

Ahlgrim C, Pottgiesser T, Robinson N, Sottas PE, Ruecker G, Schumacher YO.

Int J Lab Hematol. 2010 Oct;32(5):506-11. doi: 10.1111/j.1751-553X.2009.01213.x. Epub 2010 Feb 9.

PMID:
20148988
30.

Diurnal and exercise-related variability of haemoglobin and reticulocytes in athletes.

Schumacher YO, Wenning M, Robinson N, Sottas PE, Ruecker G, Pottgiesser T.

Int J Sports Med. 2010 Apr;31(4):225-30. doi: 10.1055/s-0029-1243617. Epub 2010 Feb 10.

PMID:
20148373
31.

Endogenous steroid profiling in the athlete biological passport.

Sottas PE, Saugy M, Saudan C.

Endocrinol Metab Clin North Am. 2010 Mar;39(1):59-73, viii-ix. doi: 10.1016/j.ecl.2009.11.003.

PMID:
20122450
32.

The athlete's biological passport and indirect markers of blood doping.

Sottas PE, Robinson N, Saugy M.

Handb Exp Pharmacol. 2010;(195):305-26. doi: 10.1007/978-3-540-79088-4_14. Review.

PMID:
20020371
33.

Blood transfusion in sports.

Giraud S, Sottas PE, Robinson N, Saugy M.

Handb Exp Pharmacol. 2010;(195):295-304. doi: 10.1007/978-3-540-79088-4_13. Review.

PMID:
20020370
34.

Steroid profiles of professional soccer players: an international comparative study.

Strahm E, Sottas PE, Schweizer C, Saugy M, Dvorak J, Saudan C.

Br J Sports Med. 2009 Dec;43(14):1126-30. doi: 10.1136/bjsm.2008.056242. Epub 2009 Mar 12.

PMID:
19282302
35.

Substantial advantage of a combined Bayesian and genotyping approach in testosterone doping tests.

Schulze JJ, Lundmark J, Garle M, Ekström L, Sottas PE, Rane A.

Steroids. 2009 Mar;74(3):365-8. doi: 10.1016/j.steroids.2008.11.003. Epub 2008 Nov 13.

PMID:
19056415
36.

An empirical hierarchical Bayesian unification of occupational exposure assessment methods.

Sottas PE, Lavoué J, Bruzzi R, Vernez D, Charrière N, Droz PO.

Stat Med. 2009 Jan 15;28(1):75-93. doi: 10.1002/sim.3411.

PMID:
18991317
37.

Total hemoglobin mass--a new parameter to detect blood doping?

Prommer N, Sottas PE, Schoch C, Schumacher YO, Schmidt W.

Med Sci Sports Exerc. 2008 Dec;40(12):2112-8. doi: 10.1249/MSS.0b013e3181820942.

PMID:
18981937
38.

Doping: a paradigm shift has taken place in testing.

Sottas PE, Saudan C, Saugy M.

Nature. 2008 Sep 11;455(7210):166. doi: 10.1038/455166a. No abstract available.

PMID:
18784700
39.

Mammographic texture synthesis: second-generation clustered lumpy backgrounds using a genetic algorithm.

Castella C, Kinkel K, Descombes F, Eckstein MP, Sottas PE, Verdun FR, Bochud FO.

Opt Express. 2008 May 26;16(11):7595-607.

PMID:
18545466
40.

Semiautomatic mammographic parenchymal patterns classification using multiple statistical features.

Castella C, Kinkel K, Eckstein MP, Sottas PE, Verdun FR, Bochud FO.

Acad Radiol. 2007 Dec;14(12):1486-99.

PMID:
18035278
41.

Possible origins of undetectable EPO in urine samples.

Lamon S, Robinson N, Sottas PE, Henry H, Kamber M, Mangin P, Saugy M.

Clin Chim Acta. 2007 Oct;385(1-2):61-6. Epub 2007 Jul 10.

PMID:
17692836
42.
43.

From population- to subject-based limits of T/E ratio to detect testosterone abuse in elite sports.

Sottas PE, Saudan C, Schweizer C, Baume N, Mangin P, Saugy M.

Forensic Sci Int. 2008 Jan 30;174(2-3):166-72. Epub 2007 May 7.

PMID:
17485185
44.

Direct detection and quantification of 19-norandrosterone sulfate in human urine by liquid chromatography-linear ion trap mass spectrometry.

Strahm E, Saudan C, Sottas PE, Mangin P, Saugy M.

J Chromatogr B Analyt Technol Biomed Life Sci. 2007 Jun 1;852(1-2):491-6. Epub 2007 Feb 15.

PMID:
17321808
45.

Effect of multiple oral doses of androgenic anabolic steroids on endurance performance and serum indices of physical stress in healthy male subjects.

Baume N, Schumacher YO, Sottas PE, Bagutti C, Cauderay M, Mangin P, Saugy M.

Eur J Appl Physiol. 2006 Nov;98(4):329-40. Epub 2006 Aug 3.

PMID:
16896724
46.

Performance characteristics of two immunoassays for the measurement of urinary luteinizing hormone.

Robinson N, Saudan C, Sottas PE, Mangin P, Saugy M.

J Pharm Biomed Anal. 2007 Jan 4;43(1):270-6. Epub 2006 Aug 1.

PMID:
16884883
47.

Bayesian detection of abnormal values in longitudinal biomarkers with an application to T/E ratio.

Sottas PE, Baume N, Saudan C, Schweizer C, Kamber M, Saugy M.

Biostatistics. 2007 Apr;8(2):285-96. Epub 2006 Jun 19.

PMID:
16785250
48.

Scaling behavior of random knots.

Dobay A, Dubochet J, Millett K, Sottas PE, Stasiak A.

Proc Natl Acad Sci U S A. 2003 May 13;100(10):5611-5. Epub 2003 Apr 29.

49.

Use of isotope ratio mass spectrometry to detect doping with oral testosterone undecanoate: inter-individual variability of 13C/12C ratio.

Baume N, Saudan C, Desmarchelier A, Strahm E, Sottas PE, Bagutti C, Cauderay M, Schumacher YO, Mangin P, Saugy M.

Steroids. 2006 May;71(5):364-70. Epub 2006 Jan 24.

PMID:
16438998
50.

Elevated and similar urinary testosterone/epitestosterone ratio in all samples of a competition testing: suspicion of a manipulation.

Robinson N, Castella V, Saudan C, Sottas PE, Schweizer C, Dimo-Simonin N, Mangin P, Saugy M.

Forensic Sci Int. 2006 Nov 10;163(1-2):148-51. Epub 2005 Dec 6.

PMID:
16337352

Supplemental Content

Loading ...
Support Center